Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This phase III trial compares cetuxumab to chemotherapy, carboplatin and paclitaxel, with intensity modulated radiation therapy for the treatment of patients with head and neck cancer who are unable to receive cisplatin. Cetuximab is in a class of medications called monoclonal antibodies. It binds to a protein called EGFR, which is found on some types of cancer cells. This may help keep cancer cells from growing. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Paclitaxel is in a class of medications called antimicrotubule agents. It stops cancer cells from growing and dividing and may kill them. Intensity modulated radiation therapy is a type of 3-dimensional radiation therapy that uses computer-generated images to show the size and shape of the tumor. Thin beams of radiation of different intensities are aimed at the tumor from many angles. This type of radiation therapy reduces the damage to healthy tissue near the tumor. It is not yet know if cetxiumab or chemotherapy, with intensity modulated radiation therapy works best for the treatment of patients with head and neck cancer who are unable to receive cisplatin.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony mikroskopowo rak płaskonabłonkowy głowy i szyi (gardła, krtani, farynksu dolnego lub jamy ustnej), który wcześniej nie był leczony
- •Nowotwór w zaawansowanym stadium (nie rozprzestrzenil się na odległe narządy, ale zajmuje duży obszar)
- •Dla pacjentów z rakiem gardła: przeprowadzony test na białko p16
- •Pacjent nie może otrzymać cisplatyny (lek podstawowy w tym leczeniu)
- •Nowotwór nie był wcześniej operacyjnie usunięty
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- August 17, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (63)
Tower Cancer Research Foundation
Beverly Hills, United States
USC / Norris Comprehensive Cancer Center
Los Angeles, United States
Cedars-Sinai Medical Center
Los Angeles, United States
Helen F Graham Cancer Center
Newark, United States
Medical Oncology Hematology Consultants PA
Newark, United States
Christiana Care Health System-Christiana Hospital
Newark, United States
Christiana Care Health System-Wilmington Hospital
Wilmington, United States
Bay Pines VA Healthcare System
Bay Pines, United States
OSF Saint Joseph Medical Center
Bloomington, United States
Illinois CancerCare-Bloomington
Bloomington, United States
Illinois CancerCare-Canton
Canton, United States
Illinois CancerCare-Carthage
Carthage, United States
Northwestern University
Chicago, United States
Cancer Care Specialists of Illinois - Decatur
Decatur, United States
Decatur Memorial Hospital
Decatur, United States
Illinois CancerCare-Eureka
Eureka, United States
Illinois CancerCare-Galesburg
Galesburg, United States
Northwestern Medicine Glenview Outpatient Center
Glenview, United States
Northwestern Medicine Grayslake Outpatient Center
Grayslake, United States
Illinois CancerCare-Kewanee Clinic
Kewanee, United States
Northwestern Medicine Lake Forest Hospital
Lake Forest, United States
Illinois CancerCare-Macomb
Macomb, United States
Cancer Care Center of O'Fallon
O'Fallon, United States
HSHS Saint Elizabeth's Hospital
O'Fallon, United States
Northwestern Medicine Orland Park
Orland Park, United States
Illinois CancerCare-Ottawa Clinic
Ottawa, United States
Illinois CancerCare-Pekin
Pekin, United States
Illinois CancerCare-Peoria
Peoria, United States
OSF Saint Francis Radiation Oncology at Peoria Cancer Center
Peoria, United States
OSF Saint Francis Medical Center
Peoria, United States
Illinois CancerCare-Peru
Peru, United States
Illinois CancerCare-Princeton
Princeton, United States
Illinois CancerCare - Washington
Washington, United States
Mercy Hospital
Cedar Rapids, United States
Oncology Associates at Mercy Medical Center
Cedar Rapids, United States
University of Kansas Cancer Center
Kansas City, United States
University of Kansas Cancer Center-Overland Park
Overland Park, United States
University of Kansas Hospital-Indian Creek Campus
Overland Park, United States
University of Kansas Health System Saint Francis Campus
Topeka, United States
University of Kansas Hospital-Westwood Cancer Center
Westwood, United States
University of Kentucky/Markey Cancer Center
Lexington, United States
The James Graham Brown Cancer Center at University of Louisville
Louisville, United States
UofL Health Medical Center Northeast
Louisville, United States
Saint Francis Medical Center
Cape Girardeau, United States
University of Kansas Cancer Center - Briarcliff
Kansas City, United States
University of Kansas Cancer Center - North
Kansas City, United States
University of Kansas Cancer Center - Lee's Summit
Lee's Summit, United States
Stony Brook University Medical Center
Stony Brook, United States
University of Cincinnati Cancer Center-UC Medical Center
Cincinnati, United States
ProMedica Flower Hospital
Sylvania, United States
ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital
Toledo, United States
University of Cincinnati Cancer Center-West Chester
West Chester, United States
Christiana Care Health System-Concord Health Center
Chadds Ford, United States
Aspirus Cancer Care-Antigo-Volm Cancer Center
Antigo, United States
Froedtert Menomonee Falls Hospital
Menomonee Falls, United States
Medical College of Wisconsin
Milwaukee, United States
Froedtert and MCW Moorland Reserve Health Center
New Berlin, United States
Drexel Town Square Health Center
Oak Creek, United States
Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
Rhinelander, United States
Aspirus Cancer Care - Stevens Point
Stevens Point, United States
Aspirus Cancer Care-Wausau
Wausau, United States
Froedtert West Bend Hospital/Kraemer Cancer Center
West Bend, United States
Aspirus Cancer Care - Wisconsin Rapids
Wisconsin Rapids, United States
Trial contact
Site Public Contact
Zachary S. Zumsteg
PRINCIPAL_INVESTIGATOR
Site Public Contact
Jacob S. Thomas
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Gregory A. Masters
PRINCIPAL_INVESTIGATOR
Site Public Contact
Ryan J. Burri
PRINCIPAL_INVESTIGATOR
Site Public Contact
Bryan A. Faller
PRINCIPAL_INVESTIGATOR
Site Public Contact
Laila A. Gharzai
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Site Public Contact
Site Public Contact
Site Public Contact
Deborah W. Wilbur
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Christopher Lominska
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Susanne M. Arnold
PRINCIPAL_INVESTIGATOR
Site Public Contact
Rebecca A. Redman
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Site Public Contact
Site Public Contact
Achuta K. Guddati
PRINCIPAL_INVESTIGATOR
Site Public Contact
Kerri McGovern
PRINCIPAL_INVESTIGATOR
Site Public Contact
Ahmed G. Elsayed
PRINCIPAL_INVESTIGATOR
Site Public Contact
Andrew J. Huang
PRINCIPAL_INVESTIGATOR
Site Public Contact
Musaddiq J. Awan
PRINCIPAL_INVESTIGATOR
Site Public Contact
Site Public Contact
Site Public Contact
Site Public Contact
Site Public Contact
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/18/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.